News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Andrade Robert
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/30/2023 |
4
| Andrade Robert (CFO) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Sold 10,000 shares
@ $8.99, valued at
$89.9k
Sold 7,500 shares
@ $8.97, valued at
$67.3k
Sold 7,500 shares
@ $8.82, valued at
$66.2k
Exercised 25,000 options to buy
@ $2.45, valued at
$61.3k
|
|
| 06/29/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/03/2023 |
4
| Andrade Robert (CFO) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Granted 75,000 options to buy
@ $8.32, valued at
$624k
Granted 37,500 options to buy
@ $0 |
|
| 12/30/2022 |
4
| Andrade Robert (CFO) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Sold 11,000 shares
@ $9.6145, valued at
$105.8k
Sold 5,500 shares
@ $9.5748, valued at
$52.7k
Sold 5,500 shares
@ $9.6122, valued at
$52.9k
|
|
| 09/22/2022 |
4
| Andrade Robert (CFO) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Granted 37,500 shares
@ $0
Disposed/sold 19,052 shares
@ $8.54, valued at
$162.7k
|
|
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2020 |
4
| Andrade Robert (CFO) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Exercised 323,961 shares
@ $1.85, valued at
$599.3k
Paid exercise price by delivering 97,136 shares
@ $6.17, valued at
$599.3k
Paid exercise price by delivering 38,828 shares
@ $5.77, valued at
$224k
Paid exercise price by delivering 38,900 shares
@ $5.68, valued at
$221k
Paid exercise price by delivering 12,874 shares
@ $5.71, valued at
$73.5k
|
|
| 05/15/2020 |
4
| Andrade Robert (CFO) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Granted 125,000 options to buy
@ $6.93, valued at
$866.3k
|
|
| 04/08/2019 |
4
| Andrade Robert (CFO) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Granted 80,000 options to buy
@ $4.83, valued at
$386.4k
|
|
| 08/17/2018 |
4
| Andrade Robert (CFO) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Exercised 17,050 shares
@ $1.44, valued at
$24.6k
|
|
| 02/08/2018 |
4
| Andrade Robert (CFO) has filed a Form 4 on FENNEC PHARMACEUTICALS INC.|
Txns:
| Granted 50,000 options to buy
@ $8.38, valued at
$419k
|
|
| 09/20/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/20/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/17/2009 |
3
| Form 3 -- Initial statement of beneficial ownership of securities |
|
|